David Szekeres
2023
In 2023, David Szekeres earned a total compensation of $1.9M as Executive Vice President, Chief Commercial Officer at Heron Therapeutics, a 31% increase compared to previous year.
Compensation breakdown
| Salary | $305,539 |
|---|---|
| Stock Awards | $400,920 |
| Other | $1,170,920 |
| Total | $1,877,379 |
Szekeres received $1.2M in other compensation, accounting for 62% of the total pay in 2023.
Szekeres also received $305.5K in salary and $400.9K in stock awards.
Rankings
In 2023, David Szekeres' compensation ranked 574th out of 3,006 executives tracked by ExecPay. In other words, Szekeres earned more than 80.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 574 out of 3,006 | 81st |
Division Manufacturing | 326 out of 1,650 | 80th |
Major group Chemicals And Allied Products | 227 out of 918 | 75th |
Industry group Drugs | 224 out of 881 | 75th |
Industry Pharmaceutical Preparations | 140 out of 637 | 78th |
Source: SEC filing on April 29, 2024.
Szekeres' colleagues
We found four more compensation records of executives who worked with David Szekeres at Heron Therapeutics in 2023.
News
Heron Therapeutics CEO Craig Collard receives $11M in 2023
April 29, 2024
Heron Therapeutics Executive Vice President, Drug Development Kimberly Manhard's 2022 pay falls 22% to $1.4M
May 1, 2023
Heron Therapeutics CEO Barry Quart's 2021 pay rises 2% to $5.4M
April 25, 2022
Heron Therapeutics CEO Barry Quart's 2020 pay slips 9% to $5.3M
April 22, 2021